We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 163

Athens Court confirms validity of Janssen’s Patent and grants high amount of compensations
  • Dr Helen G Papaconstantinou and Partners Law Firm
  • Greece
  • December 6 2017

In Janssen Pharmaceutica N.V. against Greek pharmaceutical companies (Decision no. 21112017, June 22, 2017) the Athens Court of First Instance


Life Sciences: Compliance and enforcement in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • November 22 2017

A structured guide to compliance and dishonest practices in Greece


Clinical trials in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • November 22 2017

A structured guide to clinical trials in Greece


Pharmacovigilance in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • November 22 2017

A structured guide to Pharmacovigilance in Greece


Life Sciences: product regulation and liability in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • November 22 2017

A structured guide to product regulation and liability laws in Greece


Off-label use of medicine and medical malpractice: court finds ophthalmologist liable for vision loss
  • Zemberis, Markezinis, Lambrou & Associates
  • Greece
  • June 21 2017

The First-Instance Court of Athens recently found an ophthalmologist liable for injury suffered by his patient when the latter lost vision from one


Antitrust and competition - the EU weekly briefing (14 March 2016)
  • Winston & Strawn LLP
  • United Kingdom, Denmark, European Union, France, Greece
  • March 14 2016

Commission approves McKesson acquisition of UDG Healthcare in the EEA but refers UK element to the CMA for approval. On 4 March 2016


Greece
  • Vayanos Kostopoulos
  • Greece
  • September 17 2013

The most important legislative sources for pharmaceutical trademarks are: the new Trademarks Law (40722012), as modified by Law 41552013


Smith & Nephew PLC settlement illustrates pitfalls of ignoring red flags
  • Jenner & Block LLP
  • USA, United Kingdom, Greece
  • April 30 2012

A London-based medical device company, Smith & Nephew PLC, has settled an FCPA matter with DOJ and SEC involving bribes to public sector doctors in Greece by U.S. and German subsidiaries of Smith & Nephew


Antitrust, competition and economic regulation client quarterly newsletter
  • Hogan Lovells
  • USA, China, European Union, Greece
  • January 24 2012

A public company CEO recently consented to a federal district court order requiring him to pay a $500,000 civil penalty for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”